SOPVX
Price
$48.44
Change
-$0.00 (-0.00%)
Updated
Jun 2 closing price
Net Assets
1.79B
VIGRX
Price
$214.29
Change
+$1.43 (+0.67%)
Updated
Jun 2 closing price
Net Assets
269.26B
Interact to see
Advertisement

SOPVX vs VIGRX

Header iconSOPVX vs VIGRX Comparison
Open Charts SOPVX vs VIGRXBanner chart's image
Allspring Opportunity A
Price$48.44
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets1.79B
Vanguard Growth Index Investor
Price$214.29
Change+$1.43 (+0.67%)
VolumeN/A
Net Assets269.26B
SOPVX vs VIGRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SOPVX vs. VIGRX commentary
Jun 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SOPVX is a Buy and VIGRX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 269B vs. SOPVX (1.79B). VIGRX pays higher dividends than SOPVX: VIGRX (0.35) vs SOPVX (0.00). SOPVX was incepted earlier than VIGRX: SOPVX (25 years) vs VIGRX (33 years). SOPVX (1.19) is less costly to investors than VIGRX (0.17). SOPVX is a more actively managed with annual turnover of: 20.00 vs. VIGRX (11.00). SOPVX has a lower initial minimum investment than VIGRX: SOPVX (1000) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 17.83 vs. SOPVX (-3.43). VIGRX return over 5 years is better than : 109.40 vs. SOPVX (13.47).
SOPVXVIGRXSOPVX / VIGRX
Total Expense Ratio1.170.17688%
Annual Report Gross Expense Ratio1.190.17700%
Fund Existence25 years33 years-
Gain YTD-3.9270.743-528%
Front Load6%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets1.79B269B1%
Annual Yield % from dividends0.000.35-
Returns for 1 year-3.4317.83-19%
Returns for 3 years4.9670.067%
Returns for 5 years13.47109.4012%
Returns for 10 years-0.06281.42-0%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PMCB1.070.04
+4.35%
PharmaCyte Biotech
IKT2.050.04
+1.99%
Inhibikase Therapeutics
AC37.780.46
+1.23%
Associated Capital Group
GBDC15.14-0.07
-0.46%
Golub Capital BDC
CAG22.76-0.13
-0.57%
Conagra Brands